These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2428144)

  • 1. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma.
    Raphanaud D; Borensztejn M; Dupeyron JP; Guyon F
    Ther Drug Monit; 1986; 8(3):365-7. PubMed ID: 2428144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the EMIT procainamide and N-acetylprocainamide assay.
    Walberg CB; Wan SH
    Ther Drug Monit; 1979; 1(1):47-56. PubMed ID: 95422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme immunoassay, liquid chromatography, and spectrofluorometry compared for the determination of procainamide and N-acetylprocainamide in serum.
    Pape BE
    J Anal Toxicol; 1982; 6(1):44-8. PubMed ID: 6176781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.
    Lai CM; Kamath BL; Look ZM; Yacobi A
    J Pharm Sci; 1980 Aug; 69(8):982-4. PubMed ID: 6157019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method.
    MacKichan JJ; Coyle JD; Shields BJ; Boudoulas H; Lima JJ
    Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of serum procainamide and N-acetylprocainamide: a comparison of emit and reverse-phase high-performance liquid chromatography.
    Griffiths WC; Dextraze P; Hayes M; Mitchell J; Diamond I
    Clin Toxicol; 1980 Mar; 16(1):51-4. PubMed ID: 6156051
    [No Abstract]   [Full Text] [Related]  

  • 7. Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.
    vasBinder E; Annesley T
    Biomed Chromatogr; 1991 Jan; 5(1):19-22. PubMed ID: 1709575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of procainamide and N-acetylprocainamide by "high-performance" liquid chromatography.
    Stearns FM
    Clin Chem; 1981 Dec; 27(12):2064-7. PubMed ID: 6171366
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved liquid chromatographic determination of procainamide and N-acetylprocainamide in serum.
    Patel CP
    Ther Drug Monit; 1983 Jun; 5(2):235-8. PubMed ID: 6192559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High performance liquid chromatographic method for determination of procainamide and its active metabolites, N-acetylprocainamide in serum].
    Zhang SQ; Olugo-Edege GC; Zhu YP; Mao FF; An DK
    Yao Xue Xue Bao; 1988 Jun; 23(6):430-4. PubMed ID: 2463733
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI; Thenot JP; Stec GP; Atkinson AJ
    Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantitation of quinidine, procainamide, and N-acetylprocainamide in serum by gas-liquid chromatography with a nitrogen-phosphorus selective detector.
    Kessler KM; Ho-Tung P; Steele B; Silver J; Pickoff A; Narayanan S; Myerburg RJ
    Clin Chem; 1982 May; 28(5):1187-90. PubMed ID: 6176367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
    Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
    J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Fluoroimmunoassays for the determination of individual or combined levels of procainamide and N-acetylprocainamide in serum.
    Al-Hakiem MH; Smith DS; Landon J
    J Immunoassay; 1982; 3(1):91-110. PubMed ID: 6182162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.
    Dutcher JS; Strong JM
    Clin Chem; 1977 Jul; 23(7):1318-20. PubMed ID: 872378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved semi-automated analysis of procainamide and N-acetyl procainamide utilizing a totally volatile mobile phase.
    Quattrone AJ; Putnam RS
    J Anal Toxicol; 1981; 5(2):101-4. PubMed ID: 6165861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum drug concentrations in patients with ischemic heart disease after administration of a sustained release procainamide preparation.
    Zema MJ; Mirando T
    Angiology; 1983 Jan; 34(1):32-9. PubMed ID: 6186164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of procainamide and N-acetylprocainamide in serum by high-performance liquid chromatography.
    Shukur LR; Powers JL; Marques RA; Winter ME; Sadée W
    Clin Chem; 1977; 23(4):636-8. PubMed ID: 844158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.